More about this topic
Business
Google ordered to pay Klarna €1.7 billion over search abuse
A Swedish court has ordered Google to pay 14.3 billion Swedish kronor plus interest (€1.7bn) in damages to PriceRunner, the price-comparison service owned by fintech group Klarna, ruling that the technology giant unlawfully favoured its own shopping service for years.
Travel News
Visa’s new platform promises travel perks in European destinations
The new Visa Destinations platform brings together dining, shopping, entertainment, culture, hotel and wellness recommendations and offers for travellers. It’s initially rolling out across 10 major destinations, including three in Europe.
Economy
Inflation tumbled in June: where did prices cool the most in Europe?
Inflation fell more than expected across the single-currency bloc in June, easing pressure on the European Central Bank (ECB) and reviving hopes that the energy-driven spike triggered by the war in the Middle East is finally fading.
Europe News
Russia closes railway borders with Finland, Estonia and Latvia
In an unexpected move, Russia announced several railway border crossings with Finland, Estonia and Latvia to be “temporarily” shut down. Could this indicate an upcoming mobilisation in Russia as Moscow lacks troops for its ongoing all-out war against Ukraine?
Markets
€37tn in savings: Why EU countries resist a unified capital market?
Despite capital markets integration being a top priority for EU leadership, member states remain reluctant to deepen it further. A full European capital markets union comparable to the US remains out of reach, even though it is seen as necessary to compete in strategic sectors like AI and defence.
Europe Today
EPP boss speaks exclusively to Euronews as von der Leyen visits Baku
Manfred Weber, President of the European People's Party, speaks exclusively to Euronews as European Commission chief Ursula von der Leyen visits Azerbaijan to build on EU influence in a region traditionally in Russia's orbit.
Health news
Billions of mRNA vaccine doses’ review underpins their effectiveness
A review of data covering billions of doses of mRNA vaccines has found "compelling" evidence that the technology is both safe and highly effective against infectious diseases, with researchers arguing that the focus should now shift to improving access.